Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.76 CAD | -2.56% | +0.92% | +58.12% |
Sales 2024 * | 3.01Cr 2.21Cr 183.45Cr | Sales 2025 * | 2.94Cr 2.15Cr 178.92Cr | Capitalization | 21Cr 15Cr 1.29TCr |
---|---|---|---|---|---|
Net income 2024 * | 1.8Cr 1.32Cr 109.54Cr | Net income 2025 * | 1.6Cr 1.17Cr 97Cr | EV / Sales 2024 * | 7.01 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 7.18 x |
P/E ratio 2024 * |
11.8
x | P/E ratio 2025 * |
13.5
x | Employees | 5 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.03% |
Latest transcript on Cipher Pharmaceuticals Inc.
1 day | -2.56% | ||
1 week | +0.92% | ||
1 month | +0.92% | ||
3 months | +21.33% | ||
6 months | +38.39% | ||
Current year | +58.12% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
Bryan Jacobs
DFI | Director of Finance/CFO | - | 15/22/15 |
James Bowen
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Harold Wolkin
BRD | Director/Board Member | 72 | 08/16/08 |
Douglas N. Deeth
BRD | Director/Board Member | 76 | 21/23/21 |
Craig Mull
CEO | Chief Executive Officer | - | 26/19/26 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 8.76 | -2.56% | 8,643 |
30/24/30 | 8.99 | +1.24% | 8,886 |
29/24/29 | 8.88 | -0.67% | 12,426 |
28/24/28 | 8.94 | +2.17% | 20,525 |
27/24/27 | 8.75 | +0.81% | 6,207 |
Delayed Quote Toronto S.E., May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.12% | 15Cr | |
+40.73% | 74TCr | |
+31.99% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+14.34% | 24TCr | |
+9.27% | 21TCr | |
-5.48% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- CPH Stock